You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 1, January 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (247)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Symptoms of Tobacco Withdrawal

A Replication and Extension

John R. Hughes, MD; Steven W. Gust, PhD; Kelli Skoog; Robert M. Keenan, PhD; James W. Fenwick, PhD

Arch Gen Psychiatry. 1991;48(1):52-59.


Abstract

• Smokers (n = 315) who wished to quit were randomly assigned in a double-blind manner to groups using either nicotine or placebo gum. Self-reported and observed symptoms of tobacco withdrawal were collected before cessation and at follow-ups of 1 to 2 weeks, 1 month, and 6 months. Self-reported and/or observed anger, anxiety, craving, difficulty concentrating, hunger, impatience, and restlessness were the most prominent symptoms of tobacco withdrawal. These symptoms had returned to precessation levels by 1 month except increased weight, hunger, and craving continued for 6 months in many smokers. Nicotine gum decreased most symptoms, including craving and hunger but not weight. Abstinent smokers with more intense withdrawal were not more likely to relapse. Abstinent smokers who gained more weight were less likely to relapse.



Author Affiliations

From the Departments of Psychiatry, Psychology, Family Practice (Dr Hughes), and Medical Biostatistics (Dr Fenwick), University of Vermont, Burlington; the National Institute on Drug Abuse (Dr Gust), Bethesda, Md; and the Departments of Psychiatry and Psychology (Ms Skoog and Dr Keenan), University of Minnesota, Minneapolis.


Footnotes

Accepted for publication February 13, 1990.

Read before the annual meeting of the Association for Behavior Analysis, Boston, Mass, November 17, 1987.

Reprint requests to Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT 05405 (Dr Hughes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

DRD2-related TaqIA polymorphism modulates motivation to smoke
Zuo et al.
Nicotine Tob Res 2009;11:1321-1329.
ABSTRACT | FULL TEXT  

Mood, nicotine, and dose expectancy effects on acute responses to nicotine spray
Perkins et al.
Nicotine Tob Res 2009;11:540-546.
ABSTRACT | FULL TEXT  

ASHP Therapeutic Position Statement on the Cessation of Tobacco Use
Hudmon and Corelli
Am J Health Syst Pharm 2009;66:291-307.
FULL TEXT  

Severity of tobacco abstinence symptoms varies by time of day
Perkins et al.
Nicotine Tob Res 2009;0:ntn003v1-ntn003.
ABSTRACT | FULL TEXT  

Nicotine administration and withdrawal affect survival in systemic inflammation models
Steiner et al.
J. Appl. Physiol. 2008;105:1028-1034.
ABSTRACT | FULL TEXT  

Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi and Salas
Exp. Biol. Med. 2008;233:917-929.
ABSTRACT | FULL TEXT  

Treatment of tobacco dependence: integrating recent progress into practice
Le Foll and George
CMAJ 2007;177:1373-1380.
ABSTRACT | FULL TEXT  

Nicotine increases ethanol preference but decreases locomotor activity during the initial stages of chronic ethanol withdrawal
Lallemand et al.
Alcohol Alcohol 2007;42:207-218.
ABSTRACT | FULL TEXT  

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Tonnesen et al.
Eur Respir J 2007;29:390-417.
ABSTRACT | FULL TEXT  

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad et al.
JAMA 2006;296:64-71.
ABSTRACT | FULL TEXT  

The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine
Nowakowska et al.
Hum Exp Toxicol 2006;25:199-209.
ABSTRACT  

What to Do With a Patient Who Smokes
Schroeder
JAMA 2005;294:482-487.
ABSTRACT | FULL TEXT  

Decreased Signs of Nicotine Withdrawal in Mice Null for the {beta}4 Nicotinic Acetylcholine Receptor Subunit
Salas et al.
J. Neurosci. 2004;24:10035-10039.
ABSTRACT | FULL TEXT  

Psychological Intervention and Antidepressant Treatment in Smoking Cessation
Hall et al.
Arch Gen Psychiatry 2002;59:930-936.
ABSTRACT | FULL TEXT  

Smoking and Panic Disorder
Valenca et al.
Psychiatr. Serv. 2001;52 :1105-1106.
FULL TEXT  

Phenotypic Characterization of an alpha 4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse
Ross et al.
J. Neurosci. 2000;20:6431-6441.
ABSTRACT | FULL TEXT  

Reward and Somatic Changes during Precipitated Nicotine Withdrawal in Rats: Centrally and Peripherally Mediated Effects
Watkins et al.
J. Pharmacol. Exp. Ther. 2000;292:1053-1064.
ABSTRACT | FULL TEXT  

Tobacco Dependence and the Nicotine Patch: Clinical Guidelines for Effective Use
Fiore et al.
JAMA 1992;268:2687-2694.
ABSTRACT  

Long-term Use of Nicotine vs Placebo Gum
Hughes et al.
Arch Intern Med 1991;151:1993-1998.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.